1. Geniposide prevents rotenone-induced apoptosis in primary cultured neurons
- Author
-
Yan-qing Han, Juan Zhao, Guanglai Li, Ke Liu, Lin Li, and Yue-Ze Liu
- Subjects
Agonist ,caspase-3 ,medicine.drug_class ,Caspase 3 ,Pharmacology ,Neuroprotection ,lcsh:RC346-429 ,geniposide ,rotenone ,chemistry.chemical_compound ,Developmental Neuroscience ,Lactate dehydrogenase ,Medicine ,Bcl-2 ,Receptor ,nerve regeneration ,lcsh:Neurology. Diseases of the nervous system ,biology ,cell apoptosis ,business.industry ,Rotenone ,Alzheimer's disease ,biology.organism_classification ,Alzheimer′s disease ,neural regeneration ,Gardenia ,chemistry ,Apoptosis ,business ,Neuroscience ,Research Article - Abstract
Geniposide, a monomer extracted from gardenia and widely used in Chinese medicine, is a novel agonist at the glucagon-like peptide-1 receptor. This receptor is involved in neuroprotection. In the present study, we sought to identify an anti-apoptotic mechanism for the treatment of neurodegenerative diseases. Primary cultured neurons were treated with different concentrations of rotenone for 48 hours. Morphological observation, cell counting kit-8 assay, lactate dehydrogenase detection and western blot assay demonstrated that 0.5 nM rotenone increased lactate dehydrogenase release, decreased the expression of procaspase-3 and Bcl-2, and increased cleaved caspase-3 expression in normal neurons. All these effects were prevented by geniposide. Our results indicate that geniposide diminished rotenone-induced injury in primary neurons by suppressing apoptosis. This may be one of the molecular mechanisms underlying the efficacy of geniposide in the treatment of neurodegenerative diseases.
- Published
- 2015